{"DataElement":{"publicId":"14235255","version":"1","preferredName":"Medical History Domain Neoplasm CNS Diagnosis WHO Classification of Tumors","preferredDefinition":"WHO classifications on CNS tumor diagnosis category.","longName":"MH_MHCAT_CNSDXCAT","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"14235254","version":"1","preferredName":"Medical History Domain Neoplasm CNS Diagnosis WHO Classification of Tumors","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to subject medical history.:5 - LLT  V 25.1_The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._A classification of benign and malignant tumors by World Health Organization (WHO) experts based primarily on histologic findings.","longName":"6401571v1.00:14235253v1.00","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"6401571","version":"1","preferredName":"Medical History Domain","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to subject medical history.","longName":"C49603","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medical History Domain","conceptCode":"C49603","definition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to subject medical history.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"738FDBAB-92FD-1DB7-E053-F662850A27F3","latestVersionIndicator":"Yes","beginDate":"2018-08-16","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-16","modifiedBy":"ONEDATA","dateModified":"2018-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"14235253","version":"1","preferredName":"Neoplasm CNS Diagnosis WHO Classification of Tumors","preferredDefinition":"5 - LLT  V 25.1_The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._A classification of benign and malignant tumors by World Health Organization (WHO) experts based primarily on histologic findings.","longName":"10028992:C15220:C113304","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm CNS","conceptCode":"10028992","definition":"5 - LLT  V 25.1","evsSource":"MEDDRA_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"WHO Classification of Tumors","conceptCode":"C113304","definition":"A classification of benign and malignant tumors by World Health Organization (WHO) experts based primarily on histologic findings.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"01CEBF92-8D68-4F5E-E063-731AD00A35DF","latestVersionIndicator":"Yes","beginDate":"2023-07-31","endDate":null,"createdBy":"LISU","dateCreated":"2023-07-31","modifiedBy":"LISU","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"01CEBF92-8D69-4F5E-E063-731AD00A35DF","latestVersionIndicator":"Yes","beginDate":"2023-07-31","endDate":null,"createdBy":"LISU","dateCreated":"2023-07-31","modifiedBy":"GDEEN","dateModified":"2023-08-01","changeDescription":null,"administrativeNotes":"07/31/2023: created for COG CADSR0002649. -SL","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"14235229","version":"1","preferredName":"WHO Classification of Tumors of Central Nervous System Diagnosis Category","preferredDefinition":"A classification of benign and malignant tumors by World Health Organization (WHO) experts based primarily on histologic findings._The part of the nervous system that consists of the brain, spinal cord, and meninges._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._A grouping of items based on some commonality or by user defined characteristics.","longName":"14235229v1.00","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"High-Grade Glioma","valueDescription":null,"ValueMeaning":{"publicId":"14235230","version":"1","preferredName":"Malignant Brain Glioma","longName":"14235230v1.00","preferredDefinition":"A grade 3 or grade 4 glioma arising from the central nervous system. This category includes glioblastoma, anaplastic astrocytoma, anaplastic ependymoma, anaplastic oligodendroglioma, and anaplastic oligoastrocytoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Glioma","conceptCode":"C4822","definition":"A grade 3 or grade 4 glioma arising from the central nervous system. This category includes glioblastoma, anaplastic astrocytoma, anaplastic ependymoma, anaplastic oligodendroglioma, and anaplastic oligoastrocytoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"01CAA436-CB64-1B46-E063-731AD00AA173","latestVersionIndicator":"Yes","beginDate":"2023-07-31","endDate":null,"createdBy":"LISU","dateCreated":"2023-07-31","modifiedBy":"LISU","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"01CAA436-CB67-1B46-E063-731AD00AA173","beginDate":"2023-07-31","endDate":null,"createdBy":"LISU","dateCreated":"2023-07-31","modifiedBy":"LISU","dateModified":"2023-07-31","deletedIndicator":"No"},{"value":"Low-Grade Glioma","valueDescription":null,"ValueMeaning":{"publicId":"7315250","version":"1","preferredName":"Low Grade Glioma","longName":"7315250","preferredDefinition":"A grade I or grade II glioma arising from the central nervous system. This category includes pilocytic astrocytoma, diffuse astrocytoma, subependymal giant cell astrocytoma, ependymoma, oligodendroglioma, oligoastrocytoma, and angiocentric glioma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Grade Glioma","conceptCode":"C132067","definition":"A grade I or grade II glioma arising from the central nervous system. This category includes pilocytic astrocytoma, diffuse astrocytoma, subependymal giant cell astrocytoma, ependymoma, oligodendroglioma, oligoastrocytoma, and angiocentric glioma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7098F74-26D6-7CC5-E053-4EBD850A4F07","latestVersionIndicator":"Yes","beginDate":"2020-06-01","endDate":null,"createdBy":"MAESKEB","dateCreated":"2020-06-01","modifiedBy":"KUMMEROA","dateModified":"2022-06-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"01CAA436-CB68-1B46-E063-731AD00AA173","beginDate":"2023-07-31","endDate":null,"createdBy":"LISU","dateCreated":"2023-07-31","modifiedBy":"LISU","dateModified":"2023-07-31","deletedIndicator":"No"},{"value":"Ependymoma","valueDescription":null,"ValueMeaning":{"publicId":"2578706","version":"1","preferredName":"Ependymoma","longName":"2578706","preferredDefinition":"Ependymoma (WHO grade II) is the most common ependymal neoplasm. It is a slow growing tumor of children and young adults and is usually located intraventricularly.  It often causes clinical symptoms by blocking CSF pathways. Key histological features include perivascular pseudorosettes and ependymal rosettes.(Adapted from WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ependymoma","conceptCode":"C3017","definition":"A WHO grade 2, slow growing tumor of children and young adults, usually located intraventricularly. It is the most common ependymal neoplasm. It often causes clinical symptoms by blocking cerebrospinal fluid pathways. Key histological features include perivascular pseudorosettes and ependymal rosettes. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-007F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"01CAA436-CB69-1B46-E063-731AD00AA173","beginDate":"2023-07-31","endDate":null,"createdBy":"LISU","dateCreated":"2023-07-31","modifiedBy":"LISU","dateModified":"2023-07-31","deletedIndicator":"No"},{"value":"Medulloblastoma","valueDescription":null,"ValueMeaning":{"publicId":"2578699","version":"1","preferredName":"Medulloblastoma","longName":"2578699","preferredDefinition":"A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medulloblastoma","conceptCode":"C3222","definition":"A malignant, invasive embryonal neoplasm arising from the cerebellum or posterior fossa. It occurs predominantly in children and has the tendency to metastasize via the cerebrospinal fluid pathways. Signs and symptoms include truncal ataxia, disturbed gait, lethargy, headache, and vomiting. There are four histologic variants: classic medulloblastoma, large cell/anaplastic medulloblastoma, desmoplastic/nodular medulloblastoma, and medulloblastoma with extensive nodularity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0078-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"01CAA436-CB6A-1B46-E063-731AD00AA173","beginDate":"2023-07-31","endDate":null,"createdBy":"LISU","dateCreated":"2023-07-31","modifiedBy":"LISU","dateModified":"2023-07-31","deletedIndicator":"No"},{"value":"Atypical teratoid/rhabdoid tumor","valueDescription":null,"ValueMeaning":{"publicId":"4265197","version":"1","preferredName":"Atypical teratoid/rhabdoid tumor","longName":"4265197","preferredDefinition":"An aggressive malignant embryonal neoplasm arising from the central nervous system.  It is composed of cells with a large eccentric nucleus, prominent nucleolus, and abundant cytoplasm.  It may be associated with loss of chromosome 22.  The vast majority of cases occur in childhood.  Symptoms include lethargy, vomiting, cranial nerve palsy, headache, and hemiplegia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atypical Teratoid/Rhabdoid Tumor","conceptCode":"C6906","definition":"An aggressive malignant embryonal neoplasm arising from the central nervous system. It is composed of cells with a large eccentric nucleus, prominent nucleolus, and abundant cytoplasm. Mutations of the SMARCB1 gene or very rarely SMARCA4 (BRG1) gene are present. The vast majority of cases occur in childhood. Symptoms include lethargy, vomiting, cranial nerve palsy, headache, and hemiplegia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F68B0C53-8C4D-AAC5-E040-BB89AD436FF2","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"01CAA436-CB6B-1B46-E063-731AD00AA173","beginDate":"2023-07-31","endDate":null,"createdBy":"LISU","dateCreated":"2023-07-31","modifiedBy":"LISU","dateModified":"2023-07-31","deletedIndicator":"No"},{"value":"Other CNS Embryonal tumors","valueDescription":null,"ValueMeaning":{"publicId":"14235231","version":"1","preferredName":"Other Central Nervous System Embryonal Tumor","longName":"14235231v1.00","preferredDefinition":"Different than the one(s) previously specified or mentioned._A malignant neoplasm of embryonal origin, arising from the central nervous system.  It usually affects children.  Representative examples include ependymoblastoma, medulloblastoma, and atypical teratoid/rhabdoid tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Central Nervous System Embryonal Tumor","conceptCode":"C6990","definition":"A malignant neoplasm of embryonal origin, arising from the central nervous system.  It usually affects children.  Representative examples include ependymoblastoma, medulloblastoma, and atypical teratoid/rhabdoid tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"01CAA436-CB65-1B46-E063-731AD00AA173","latestVersionIndicator":"Yes","beginDate":"2023-07-31","endDate":null,"createdBy":"LISU","dateCreated":"2023-07-31","modifiedBy":"LISU","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"01CAA436-CB6C-1B46-E063-731AD00AA173","beginDate":"2023-07-31","endDate":null,"createdBy":"LISU","dateCreated":"2023-07-31","modifiedBy":"LISU","dateModified":"2023-07-31","deletedIndicator":"No"},{"value":"CNS Germ Cell Tumors","valueDescription":null,"ValueMeaning":{"publicId":"14235232","version":"1","preferredName":"NCI CTEP SDC Germ Cell Tumors of the CNS Sub-Category Terminology","longName":"14235232v1.00","preferredDefinition":"Germ Cell Tumors of the CNS is an NCI Cancer Therapeutic Evaluation Program (CTEP) Simplified Disease Classification (SDC) category used to organize cancer-related disease coding that harmonizes with and supports reporting based on the global standard Medical Dictionary for Drug Regulatory Reporting (MedDRA) terminology.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NCI CTEP SDC Germ Cell Tumors of the CNS Sub-Category Terminology","conceptCode":"C103048","definition":"Germ Cell Tumors of the CNS is an NCI Cancer Therapeutic Evaluation Program (CTEP) Simplified Disease Classification (SDC) category used to organize cancer-related disease coding that harmonizes with and supports reporting based on the global standard Medical Dictionary for Drug Regulatory Reporting (MedDRA) terminology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"01CAA436-CB66-1B46-E063-731AD00AA173","latestVersionIndicator":"Yes","beginDate":"2023-07-31","endDate":null,"createdBy":"LISU","dateCreated":"2023-07-31","modifiedBy":"LISU","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"01CAA436-CB6D-1B46-E063-731AD00AA173","beginDate":"2023-07-31","endDate":null,"createdBy":"LISU","dateCreated":"2023-07-31","modifiedBy":"LISU","dateModified":"2023-07-31","deletedIndicator":"No"},{"value":"Glioneuronal and neuronal tumors","valueDescription":null,"ValueMeaning":{"publicId":"14235233","version":"1","preferredName":"Glioneuronal and Neuronal Tumors","longName":"14235233v1.00","preferredDefinition":"A group of central nervous system neoplasms with a variable amount of neuronal and, less consistently, glial differentiation. They occur at a low frequency and usually carry a favorable prognosis.  Representative examples include dysplastic cerebellar gangliocytoma, desmoplastic infantile ganglioglioma, desmoplastic infantile astrocytoma, and dysembryoplastic neuroepithelial tumor. (Adapted from WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glioneuronal and Neuronal Tumors","conceptCode":"C4747","definition":"A group of central nervous system neoplasms with a variable amount of neuronal and, less consistently, glial differentiation. They occur at a low frequency and usually carry a favorable prognosis.  Representative examples include dysplastic cerebellar gangliocytoma, desmoplastic infantile ganglioglioma, desmoplastic infantile astrocytoma, and dysembryoplastic neuroepithelial tumor. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"01CADF05-E715-2BCD-E063-731AD00A4231","latestVersionIndicator":"Yes","beginDate":"2023-07-31","endDate":null,"createdBy":"LISU","dateCreated":"2023-07-31","modifiedBy":"SOKKERL","dateModified":"2024-02-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"01CADF05-E717-2BCD-E063-731AD00A4231","beginDate":"2023-07-31","endDate":null,"createdBy":"LISU","dateCreated":"2023-07-31","modifiedBy":"LISU","dateModified":"2023-07-31","deletedIndicator":"No"},{"value":"Craniopharyngioma","valueDescription":null,"ValueMeaning":{"publicId":"4265243","version":"1","preferredName":"Craniopharyngioma","longName":"4265243","preferredDefinition":"A benign, partly cystic, epithelial tumor of the sellar region, presumably derived from Rathke pouch epithelium. It affects mainly children and young adults. There are two clinicopathological forms: adamantinomatous craniopharyngioma and papillary craniopharyngioma. The most significant factor associated with recurrence is the extent of surgical resection, with lesions greater than 5 cm in diameter carrying a markedly worse prognosis. (Adapted from WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Craniopharyngioma","conceptCode":"C2964","definition":"A benign, partly cystic, epithelial tumor of the sellar region, presumably derived from Rathke pouch epithelium. It affects mainly children and young adults. There are two clinicopathological forms: adamantinomatous craniopharyngioma and papillary craniopharyngioma. The most significant factor associated with recurrence is the extent of surgical resection, with lesions greater than 5 cm in diameter carrying a markedly worse prognosis. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F68C00B1-794B-6438-E040-BB89AD4373BF","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"01CADF05-E718-2BCD-E063-731AD00A4231","beginDate":"2023-07-31","endDate":null,"createdBy":"LISU","dateCreated":"2023-07-31","modifiedBy":"LISU","dateModified":"2023-07-31","deletedIndicator":"No"},{"value":"Choroid Plexus tumors","valueDescription":null,"ValueMeaning":{"publicId":"5098756","version":"1","preferredName":"NCI CTEP SDC Choroid Plexus Tumors Sub-Category Terminology","longName":"5098756","preferredDefinition":"Choroid Plexus Tumors is an NCI Cancer Therapeutic Evaluation Program (CTEP) Simplified Disease Classification (SDC) category used to organize cancer-related disease coding that harmonizes with and supports reporting based on the global standard Medical Dictionary for Drug Regulatory Reporting (MedDRA) terminology.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NCI CTEP SDC Choroid Plexus Tumors Sub-Category Terminology","conceptCode":"C103044","definition":"Choroid Plexus Tumors is an NCI Cancer Therapeutic Evaluation Program (CTEP) Simplified Disease Classification (SDC) category used to organize cancer-related disease coding that harmonizes with and supports reporting based on the global standard Medical Dictionary for Drug Regulatory Reporting (MedDRA) terminology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"291531AB-28A9-124B-E050-BB89AD4306EA","latestVersionIndicator":"Yes","beginDate":"2016-01-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2016-01-11","modifiedBy":"LISU","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"01CADF05-E719-2BCD-E063-731AD00A4231","beginDate":"2023-07-31","endDate":null,"createdBy":"LISU","dateCreated":"2023-07-31","modifiedBy":"LISU","dateModified":"2023-07-31","deletedIndicator":"No"},{"value":"CNS Sarcoma","valueDescription":null,"ValueMeaning":{"publicId":"14235234","version":"1","preferredName":"Central Nervous System Sarcoma","longName":"14235234v1.00","preferredDefinition":"A sarcoma that arises from the central nervous system.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System Sarcoma","conceptCode":"C5153","definition":"A sarcoma that arises from the central nervous system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"01CADF05-E716-2BCD-E063-731AD00A4231","latestVersionIndicator":"Yes","beginDate":"2023-07-31","endDate":null,"createdBy":"LISU","dateCreated":"2023-07-31","modifiedBy":"SOKKERL","dateModified":"2024-02-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"01CADF05-E71A-2BCD-E063-731AD00A4231","beginDate":"2023-07-31","endDate":null,"createdBy":"LISU","dateCreated":"2023-07-31","modifiedBy":"LISU","dateModified":"2023-07-31","deletedIndicator":"No"},{"value":"Other","valueDescription":null,"ValueMeaning":{"publicId":"2559666","version":"1","preferredName":"Other","longName":"2559666","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B61F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"LISU","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"01CADF05-E71B-2BCD-E063-731AD00A4231","beginDate":"2023-07-31","endDate":null,"createdBy":"LISU","dateCreated":"2023-07-31","modifiedBy":"LISU","dateModified":"2023-07-31","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"14235228","version":"1","preferredName":"WHO Classification of Tumors Central Nervous System Diagnosis Category","preferredDefinition":"A classification of benign and malignant tumors by World Health Organization (WHO) experts based primarily on histologic findings._The part of the nervous system that consists of the brain, spinal cord, and meninges._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._A grouping of items based on some commonality or by user defined characteristics.","longName":"14235228v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"WHO Classification of Tumors","conceptCode":"C113304","definition":"A classification of benign and malignant tumors by World Health Organization (WHO) experts based primarily on histologic findings.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Central Nervous System","conceptCode":"C12438","definition":"The part of the nervous system that consists of the brain, spinal cord, and meninges.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"01CA6120-D902-10F0-E063-731AD00A3669","latestVersionIndicator":"Yes","beginDate":"2023-07-31","endDate":null,"createdBy":"LISU","dateCreated":"2023-07-31","modifiedBy":"LISU","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"01CA6120-D903-10F0-E063-731AD00A3669","latestVersionIndicator":"Yes","beginDate":"2023-07-31","endDate":null,"createdBy":"LISU","dateCreated":"2023-07-31","modifiedBy":"GDEEN","dateModified":"2023-08-01","changeDescription":null,"administrativeNotes":"07/31/2023: created for COG CADSR0002649. -SL","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"What is the CNS diagnosis category?","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"CNS diagnosis category","url":null,"context":"COG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"If yes to central pathology review and/or central molecular testing, indicate the patient's disease category","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"01CED7C3-F712-5B19-E063-731AD00A869C","latestVersionIndicator":"Yes","beginDate":"2023-07-31","endDate":null,"createdBy":"LISU","dateCreated":"2023-07-31","modifiedBy":"GDEEN","dateModified":"2023-08-01","changeDescription":null,"administrativeNotes":"2023.8.1 AQT added per email. ak 07/31/2023: created for COG CADSR0002649. -SL","unresolvedIssues":null,"deletedIndicator":"No"}}